KaloBios Pharmaceuticals Inc (NASDAQ:KBIO)

0.4631
Delayed Data
As of 11:15am ET
 -0.0169 / -3.52%
Today’s Change
0.36
Today|||52-Week Range
2.34
-73.23%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues20.3M6.1M44.0K0.00
 
 
 
 
Depreciation And Amortization595.0K304.0K298.0K310.0K
 
 
 
 
 
 
Operating ExpensesGross Income19.7M5.8M---310.0K
 
 
 
 
General Expenses20.8M29.3M40.7M36.4M
 
 
 
 
 
Research And Development17.6M24.5M32.6M26.6M
 
 
 
 
 
Total Operating Expenses21.4M29.6M41.0M36.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.2M-23.5M-40.9M-36.7M
 
 
 
 
 
Extraordinary Charge-1.1M-39.0K0.000.00
 
 
 
Interest Expense On Debt--185.0K1.1M1.2M
 
 
 
 
Other Expenses40.0K152.0K-39.0K-154.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.2M-23.5M-41.9M-38.0M
 
 
 
 
 
Net Income-2.2M-23.5M-41.9M-38.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS24.1M2.1M24.3M33.0M
 
 
 
 
 
Shares To Calculate EPS Diluted24.1M2.1M24.3M33.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.15-$11.22-$1.73-$1.15
 
 
 
 
 
EPS Diluted-$0.09-$11.22-$1.73-$1.15
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account